311 related articles for article (PubMed ID: 19252335)
1. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
Kusuhara H; Sugiyama Y
Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level.
Veiga-Matos J; Remião F; Motales A
J Pharm Pharm Sci; 2020; 23():333-356. PubMed ID: 32997956
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of xenobiotic detoxification system mediated by efflux transporters].
Suzuki H
Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710
[TBL] [Abstract][Full Text] [Related]
5. Drug transporters in pharmacokinetics.
Petzinger E; Geyer J
Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
[TBL] [Abstract][Full Text] [Related]
6. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.
Gerloff T
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):69-77. PubMed ID: 14598019
[TBL] [Abstract][Full Text] [Related]
7. Role of transport proteins in drug absorption, distribution and excretion.
Ayrton A; Morgan P
Xenobiotica; 2001; 31(8-9):469-97. PubMed ID: 11569523
[TBL] [Abstract][Full Text] [Related]
8. Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans.
Kitamura S; Maeda K; Sugiyama Y
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):617-28. PubMed ID: 18536908
[TBL] [Abstract][Full Text] [Related]
9. Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs?
Bosquillon C
J Pharm Sci; 2010 May; 99(5):2240-55. PubMed ID: 19950388
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
Kusuhara H; Sugiyama Y
Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
[TBL] [Abstract][Full Text] [Related]
11. Active efflux across the blood-brain barrier: role of the solute carrier family.
Kusuhara H; Sugiyama Y
NeuroRx; 2005 Jan; 2(1):73-85. PubMed ID: 15717059
[TBL] [Abstract][Full Text] [Related]
12. Transporter-mediated drug-drug interactions with oral antidiabetic drugs.
Klatt S; Fromm MF; König J
Pharmaceutics; 2011 Oct; 3(4):680-705. PubMed ID: 24309303
[TBL] [Abstract][Full Text] [Related]
13. Enantioselective Drug Recognition by Drug Transporters.
Uwai Y
Molecules; 2018 Nov; 23(12):. PubMed ID: 30467304
[TBL] [Abstract][Full Text] [Related]
14. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
Kivistö KT; Niemi M
Pharm Res; 2007 Feb; 24(2):239-47. PubMed ID: 17177112
[TBL] [Abstract][Full Text] [Related]
15. Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates.
Sahi J
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):409-27. PubMed ID: 16863453
[TBL] [Abstract][Full Text] [Related]
16. Implications of genetic polymorphisms in drug transporters for pharmacotherapy.
Kerb R
Cancer Lett; 2006 Mar; 234(1):4-33. PubMed ID: 16504381
[TBL] [Abstract][Full Text] [Related]
17. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
18. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.
Kindla J; Fromm MF; König J
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):489-500. PubMed ID: 19416085
[TBL] [Abstract][Full Text] [Related]
19. Renal transporters in drug development.
Morrissey KM; Stocker SL; Wittwer MB; Xu L; Giacomini KM
Annu Rev Pharmacol Toxicol; 2013; 53():503-29. PubMed ID: 23140242
[TBL] [Abstract][Full Text] [Related]
20. Transporters and xenobiotic disposition.
Kim RB
Toxicology; 2002 Dec; 181-182():291-7. PubMed ID: 12505328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
